Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0BDIBY
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
RNAse monoclonal antibody-LL2-I-131-conjugate
|
|||||
| Synonyms |
Monoclonal antibody LL2I131 RNAse conjugate; RNAse conjugate Immunomedics; RNAseLymphoCide conjugate Immunomedics
Click to Show/Hide
|
|||||
| Organization |
Immunomedics, Inc.; Gilead Sciences, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Antibody Name |
Epratuzumab
|
Antibody Info | ||||
| Antigen Name |
B-cell receptor CD22 (CD22)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||